Biomedicine and Pharmacotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 2.074 | Q1 | 95.6% | |
| 2024 | 7.5 | Q1 | 94.9% | 1.775 | Q1 | 94.2% |
| 2023 | 6.9 | Q1 | 96.3% | 1.493 | Q1 | 92.6% |
| 2022 | 7.5 | Q1 | 94.2% | 1.366 | Q1 | 91.9% |
| 2021 | 7.4 | Q1 | 93.0% | 1.194 | Q1 | 89.9% |
| 2020 | — | — | 1.323 | Q1 | 90.6% | |
| 2019 | — | — | 1.050 | Q1 | 86.7% | |
| 2018 | — | — | 0.931 | Q1 | 82.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1950-6007
ISSN
0753-3322
country
coverage
1982-2026
